We are live on ! Find out more
HOWL icon

Werewolf Therapeutics
HOWL

44 hedge funds and large institutions have $94.5M invested in Werewolf Therapeutics in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 13 increasing their positions, 12 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

21% more capital invested

Capital invested by funds: $78M → $94.5M (+$16.5M)

1.99% more ownership

Funds ownership: 68.98% → 70.97% (+2%)

8% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 12

4% less funds holding

Funds holding: 46 → 44 (-2)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

33% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 6

Holders
44
Holders Change
-2
Holders Change %
-4.35%
% of All Funds
0.76%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
4
Increased
13
Reduced
12
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PHS
PFM Health Sciences
California
+$5.89M
2
RCMNY
Rubric Capital Management (New York)
New York
+$4.14M
3
Millennium Management
Millennium Management
New York
+$1.43M
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$223K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$213K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$987K
2
PIM
Platinum Investment Management
Australia
-$564K
3
BlackRock
BlackRock
New York
-$195K
4
E
Ergoteles
New York
-$78.2K
5
LCM
Laurion Capital Management
New York
-$66.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
DTL
26
Dynamic Technology Lab
Singapore
$88K +$106K +19,558 New
Northern Trust
27
Northern Trust
Illinois
$84K +$25.7K +4,735 +34%
Renaissance Technologies
28
Renaissance Technologies
New York
$83K +$8.14K +1,500 +9%
Morgan Stanley
29
Morgan Stanley
New York
$47K -$64.1K -11,799 -53%
TRCT
30
Tower Research Capital (TRC)
New York
$30K +$22.7K +4,188 +179%
DA
31
Denali Advisors
California
$27K +$32K +5,900 New
Bank of America
32
Bank of America
North Carolina
$15K +$4.26K +784 +29%
UBS Group
33
UBS Group
Switzerland
$11K -$9.81K -1,807 -42%
JP Morgan Chase
34
JP Morgan Chase
New York
$7K -$11.9K -2,198 -59%
OLVIG
35
Oliver Lagore Vanvalin Investment Group
Michigan
$3K – – –
Citigroup
36
Citigroup
New York
$2K -$1.68K -309 -42%
Royal Bank of Canada
37
Royal Bank of Canada
Ontario, Canada
$2K +$836 +154 +66%
FP
38
Financial Perspectives
Minnesota
$1.13K – – –
CUAMC
39
China Universal Asset Management Company
China
$1K +$1.5K +277 New
CSS
40
Cubist Systematic Strategies
Connecticut
– -$54K -13,250 Closed
YIH
41
Y-Intercept (HK)
Hong Kong
– -$45K -11,124 Closed
Goldman Sachs
42
Goldman Sachs
New York
– -$45K -10,983 Closed
New York State Common Retirement Fund
43
New York State Common Retirement Fund
New York
– -$1K -187 Closed
EI
44
Ellevest Inc
New York
– -$103 -19 -61%
Wells Fargo
45
Wells Fargo
California
– +$206 +38 +76%
1
2

HOWL Hedge Fund Activity: Q3 2022 in Review

44 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Werewolf Therapeutics (HOWL) for Q3 2022, worth a combined $94.5M — up 21% from $78M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of HOWL and 4 opened new positions — a net loss of 2 holders — while 12 trimmed existing stakes and 13 added.

The largest buyer was PFM Health Sciences, adding an estimated $5.89M. The largest seller was Fidelity Investments, cutting an estimated $987K.

  • 44 institutional investors held Werewolf Therapeutics (HOWL) as of Q3 2022, down from 46 in Q2 2022.
  • Funds reported $94.5M of Werewolf Therapeutics stock for Q3 2022, up 21% quarter-over-quarter.
  • 4 funds opened new Werewolf Therapeutics positions in Q3 2022 and 6 closed out, a net change of -2 holders.
  • The largest Werewolf Therapeutics buyer in Q3 2022 was PFM Health Sciences, an estimated $5.89M added.
  • The largest Werewolf Therapeutics seller in Q3 2022 was Fidelity Investments, an estimated $987K sold.

Based on aggregated 13F filings for Q3 2022.